Communicable Diseases & Infection Control – Core Vocabulary

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/78

flashcard set

Earn XP

Description and Tags

This set of vocabulary flashcards distills essential communicable-disease, immunization, and infection-control terms drawn from the comprehensive lecture Q&A. Use them to reinforce key definitions, precautions, pathogens, vaccines, therapies, and epidemiologic concepts likely to appear on exams or in clinical practice.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

79 Terms

1
New cards

Contact Precautions

Infection-control measures (gloves, gown, hand hygiene) used when touching patients or items contaminated with infectious body fluids or organisms such as MRSA.

2
New cards

Airborne Precautions

Isolation strategy that places a patient in a negative-pressure room and requires fit-tested N95 or particulate respirators to prevent inhalation of droplet nuclei (e.g., tuberculosis, measles, varicella).

3
New cards

Droplet Precautions

Use of surgical mask within 3 ft (1 m) of a patient plus hand hygiene to block large-particle droplets (e.g., meningococcal meningitis, influenza).

4
New cards

Negative-Pressure Room

Hospital room with airflow that draws air into the room and exhausts it outdoors, preventing airborne pathogens from escaping.

5
New cards

Standard Precautions

Minimum infection-control practices (hand hygiene, personal protective equipment) applied to every patient regardless of diagnosis.

6
New cards

Methicillin-Resistant Staphylococcus aureus (MRSA)

Strain of S. aureus resistant to β-lactam antibiotics; spread mainly by hands; requires contact precautions.

7
New cards

Purified Protein Derivative (PPD)

Skin-test antigen used to screen for prior infection with Mycobacterium tuberculosis.

8
New cards

Acid-Fast Bacillus (AFB) Smear

Microscopic examination of sputum for acid-fast organisms; confirms active pulmonary tuberculosis.

9
New cards

Directly Observed Treatment, Short-Course (DOTS)

WHO-recommended TB strategy in which a health worker watches the patient swallow each dose of multidrug therapy.

10
New cards

Isoniazid (INH)

First-line antitubercular drug; prophylaxis for PPD converters; can cause peripheral neuropathy (give pyridoxine).

11
New cards

Rifampicin (Rifampin)

Key TB drug that turns body fluids orange-red; best taken on an empty stomach.

12
New cards

Streptomycin

Injectable aminoglycoside used in TB; ototoxicity manifests as vertigo or hearing loss (‘cinchonism-like’).

13
New cards

Multidrug Therapy (MDT)

Use of two or more antimicrobial agents simultaneously to prevent drug resistance, as in TB or leprosy treatment.

14
New cards

CD4 Cell Count

Measurement of helper T-cells; a count <200 cells/mm³ defines AIDS in an HIV-positive individual.

15
New cards

Opportunistic Infection

Illness (e.g., PCP, CMV, oral thrush) that exploits the weakened immune system of HIV/AIDS patients.

16
New cards

Pneumocystis carinii (jirovecii) Pneumonia

Common AIDS-defining opportunistic pneumonia treated with high-dose trimethoprim-sulfamethoxazole.

17
New cards

Anaphylaxis

Severe, rapid allergic reaction; first-line treatment is intramuscular epinephrine 1 mg/mL (1:1000).

18
New cards

Hepatitis A Virus (HAV)

Fecal-oral transmitted picornavirus; prevent with hand hygiene, safe food/water, and inactivated vaccine.

19
New cards

Hepatitis B Virus (HBV)

Blood-borne hepadnavirus; prevented by three-dose recombinant vaccine and perinatal maternal screening.

20
New cards

Tetanus Toxoid (TT)

Inactivated tetanospasmin given to pregnant women (TT1-TT5) to protect mother and newborn from tetanus.

21
New cards

Diphtheria-Pertussis-Tetanus (DPT/DTaP) Vaccine

Combination immunization given at 6, 10, 14 weeks; contraindicated after severe post-dose encephalopathy.

22
New cards

Measles-Mumps-Rubella (MMR) Vaccine

Live attenuated viral vaccine given at 9 months or later; delay after IVIG or Kawasaki immunoglobulin therapy.

23
New cards

Oral Polio Vaccine (OPV)

Live Sabin vaccine given as two oral drops; heat-sensitive and stored in freezer at −15 °C to −25 °C.

24
New cards

Bacille Calmette-Guérin (BCG)

Live attenuated Mycobacterium bovis vaccine given intradermally at birth to prevent severe childhood TB.

25
New cards

Passive Immunity

Immediate, short-term protection conferred by preformed antibodies (e.g., immune globulin, maternal IgG).

26
New cards

Active Immunity

Long-lasting protection produced by one’s own immune system after infection or vaccination.

27
New cards

Incidence Rate

Number of new cases of a disease in a population during a specific period.

28
New cards

Prevalence

Total number of existing cases (new + old) of a disease in a population at a given time.

29
New cards

Endemic

Disease constantly present in a particular geographic area (e.g., malaria in parts of Africa).

30
New cards

Epidemic

Sudden increase in disease cases above what is normally expected in a population or area.

31
New cards

Pandemic

Worldwide epidemic affecting large numbers across continents (e.g., COVID-19, 1918 influenza).

32
New cards

Nosocomial Infection

Infection acquired during hospitalization or healthcare delivery (e.g., ventilator-associated pneumonia).

33
New cards

Chain of Infection

Six links—agent, reservoir, portal of exit, mode of transmission, portal of entry, susceptible host—whose interruption prevents disease spread.

34
New cards

Hand Hygiene

Most effective routine practice to prevent transmission of infections in healthcare and home settings.

35
New cards

Salmonella

Gram-negative bacillus causing diarrhea and abdominal cramps; prevent by cooking food and handwashing.

36
New cards

Shigella

Bacillus causing bacillary dysentery; stool culture-positive cases must be reported to public health authorities.

37
New cards

Varicella-Zoster Virus (VZV)

Herpesvirus causing chickenpox and shingles; isolate until vesicles crust; airborne plus contact precautions.

38
New cards

Pediculosis Capitis

Infestation with head lice; transmitted by sharing hats/combs; treat with pediculicide and nit combing.

39
New cards

Candida albicans

Yeast that is normal flora but can cause oral/vaginal thrush in immunocompromised hosts.

40
New cards

Antigen

Foreign substance that triggers antibody formation and immune response.

41
New cards

Antibody (Immunoglobulin)

Protein produced by B-cells that binds specific antigen to neutralize or eliminate it.

42
New cards

Epinephrine 1:1000

First-choice intramuscular drug for anaphylaxis; dose 0.3–0.5 mL adult, 0.01 mg/kg child.

43
New cards

Quarantine

Restriction of movement of exposed but healthy persons during incubation period to prevent disease spread.

44
New cards

Leprosy (Hansen Disease)

Chronic Mycobacterium leprae infection affecting skin and nerves; treated with multi-drug therapy (dapsone, rifampicin, clofazimine).

45
New cards

Paucibacillary Leprosy

Type with ≤5 skin lesions and negative skin smears; 6-month MDT regimen of rifampicin + dapsone.

46
New cards

Multibacillary Leprosy

5 lesions or positive smears; 12-month MDT regimen of rifampicin, dapsone, clofazimine.

47
New cards

Schistosomiasis

Helminth infection acquired by skin contact with freshwater cercariae from snail hosts; treated with praziquantel.

48
New cards

Filariasis

Mosquito-borne Wuchereria bancrofti infection causing lymphedema/elephantiasis; treated with diethylcarbamazine (DEC).

49
New cards

Vector

Living carrier (e.g., mosquito, tick) that transmits an infectious agent from host to host.

50
New cards

Aedes aegypti

Mosquito vector for dengue, yellow fever, Zika; bites primarily during daytime.

51
New cards

Anopheles Mosquito

Vector for Plasmodium species causing malaria; feeds dusk to dawn.

52
New cards

Incubation Period

Time between entry of pathogen and appearance of first symptoms.

53
New cards

Carrier

Person who harbors a pathogen without signs of disease but can transmit it to others.

54
New cards

Kernig Sign

Inability to straighten the knee when hip is flexed to 90°; indicates meningeal irritation.

55
New cards

Koplik Spots

Small bluish-white lesions on buccal mucosa pathognomonic for measles (rubeola).

56
New cards

Orchitis

Painful testicular inflammation; potential complication of mumps in post-pubertal males.

57
New cards

Interferon

Cell-produced antiviral proteins that inhibit viral replication and modulate immune response.

58
New cards

IgG

Only immunoglobulin class that crosses the placenta, providing newborns with passive immunity.

59
New cards

IgE

Immunoglobulin mediating allergic responses and anaphylaxis.

60
New cards

DOTS Category I

Six-month TB regimen for newly diagnosed smear-positive cases: 2 HRZE/4 HR (intensive/continuation).

61
New cards

DOTS Category II

Eight-month regimen for relapse or treatment failure cases: 2 HRZES/1 HRZE/5 HRE.

62
New cards

Pyridoxine (Vitamin B₆)

Supplement given with INH to prevent peripheral neuropathy.

63
New cards

Epididymitis & Orchitis

Scrotal complications of mumps; managed with bed rest, scrotal support, analgesia.

64
New cards

Giardia lamblia

Protozoan causing foul, fatty diarrhea; transmitted via contaminated water; treat with metronidazole.

65
New cards

Trichomoniasis

Sexually transmitted infection by Trichomonas vaginalis; causes greenish malodorous discharge; treat both partners with metronidazole, avoid alcohol.

66
New cards

Meningococcal Meningitis

Neisseria meningitidis infection requiring droplet isolation and prophylaxis of contacts with rifampicin.

67
New cards

Pneumococcal Vaccine

Polysaccharide or conjugate vaccine preventing Streptococcus pneumoniae infections, especially in elders and asplenic patients.

68
New cards

Hand-Foot-Mouth Disease

Coxsackievirus infection causing oral ulcers and vesicular rash on hands/feet; supportive care, high contagion.

69
New cards

Vector Control

Public-health measures (insecticide spraying, eliminating breeding sites) to reduce disease transmitted by vectors.

70
New cards

Herd Immunity

Community-level protection achieved when a high percentage of the population is immune, reducing spread to susceptibles.

71
New cards

Erythromycin Prophylaxis (Ocular)

0.5% ophthalmic ointment applied to newborns to prevent gonococcal ophthalmia neonatorum.

72
New cards

Ceftriaxone

Single-dose IM third-generation cephalosporin; drug of choice for uncomplicated gonorrhea.

73
New cards

Chlamydia trachomatis

Most common bacterial STD; often asymptomatic; treat with doxycycline or azithromycin.

74
New cards

Impetigo

Superficial skin infection (Staph/Strep) producing honey-colored crusts; complications include post-streptococcal glomerulonephritis.

75
New cards

Intermittent Preventive Therapy (IPT)

Periodic antimalarial drug administration (e.g., sulfadoxine-pyrimethamine) to high-risk groups such as pregnant women.

76
New cards

Safety-Engineered Devices

Needles or sharps with built-in injury protection to reduce occupational exposures and needlestick-related infections.

77
New cards

Post-Exposure Prophylaxis (PEP)

Immediate medications (e.g., HIV antiretrovirals, HBV vaccine ± HBIG, rabies immunoglobulin) given after potential exposure.

78
New cards

Foodborne Illness

Diarrheal or systemic disease caused by ingestion of contaminated food or water, e.g., Salmonella, Shigella, Vibrio cholerae.

79
New cards

Boil-Water Advisory

Public-health notice instructing residents to boil tap water for at least 1 minute to inactivate pathogens.